LSD, a future antianxiety pill?
A new study by Dr. Gabriella Gobbi reveals the neurobiological mechanisms by which LSD could relieve anxiety
BCG vaccine provides protection against influenza virus but not SARS-CoV-2
A new study led by RI-MUHC researchers reveals that the 100-year-old tuberculosis vaccine known as..
What’s the signature of a healthy heart?
Instead of treating the “average person,” the Courtois Cardiovascular Signature Program aims to treat every person as a unique individual
COVID-19: A close look at vaccine strategies used with older people in Quebec
A new study determines the maximum recommended interval between the first and second doses of mRNA...
Beyond basic research: Coming to grips with a rare disease experience
To honour Rare Disease Day on February 28, an RI-MUHC research trainee shares the perspective he gained as a patient
CTN study tests new drug for the first time in people living with HIV
Postdoc Léna Royston aims to understand how cytomegalovirus infection can increase inflammation and cause health issues
RI-MUHC team uncovers new mechanism of inflammation in muscular dystrophy
A new study reveals how signals sent from damaged muscles to the bone marrow can induce long-lasting...
Fall 2021 CIHR competition results
RI-MUHC teams received $9.5 million in project funding
Three renewed Canada Research Chairs for RI-MUHC researchers
Ahmad Haidar, Dennis Jensen and Ian Watson are part of the McGill University cohort of 17 new and renewed Canada Research Chairs
Marcel Behr appointed interim director McGill Interdisciplinary Initiative in Infection and Immunity
Founding director Don Sheppard to direct Antimicrobial Resistance Task Force at the Public Health Agency...